Alkermes Plc (NASDAQ:ALKS)

During the Trading Day
44.12 -0.91 / -2.02%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
44.67 +0.55 / +1.24%
Volume: 18.7K
Health Technology

Company Description

Alkermes Plc is engaged in the development, manufacture and distribution of medicines. Its products address the following diseases: Multiple Sclerosis Complication, Opioid and Alcohol Dependence, Schizophrenia, Bipolar Disorder and Type 2 Diabetes. Some of its medicine brands are Risperdal, Consta, Invega, Sustenna, Xeplion, Ampyra, Fampyra, Bydureon, Vivitrol, Tricor, Lipanthyl, Lipidil, Supralip, Zanaflex, Avinza, and Emend. The company was founded on September 16, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin 4
P:(531) 772-8000
Investor Relations:



Mutual fund holders68.64%
Other institutional22.79%
Individual stakeholders0.74%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane CookePresident
Gordon G. PughSenior VP, Chief Operating & Risk Officer
James M. FratesChief Financial Officer, Treasurer & Senior VP
Srdjan R. StankovicSenior VP-Clinical Development & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.